Title |
The Aminopeptidase Inhibitor CHR-2863 Is an Orally Bioavailable Inhibitor of Murine Malaria
|
---|---|
Published in |
Antimicrobial Agents and Chemotherapy, March 2012
|
DOI | 10.1128/aac.06245-11 |
Pubmed ID | |
Authors |
Tina S. Skinner-Adams, Christopher L. Peatey, Karen Anderson, Katharine R. Trenholme, David Krige, Christopher L. Brown, Colin Stack, Desire M. M. Nsangou, Rency T. Mathews, Karine Thivierge, John P. Dalton, Donald L. Gardiner |
Abstract |
Malaria remains a significant risk in many areas of the world, with resistance to the current antimalarial pharmacopeia an ever-increasing problem. The M1 alanine aminopeptidase (PfM1AAP) and M17 leucine aminopeptidase (PfM17LAP) are believed to play a role in the terminal stages of digestion of host hemoglobin and thereby generate a pool of free amino acids that are essential for parasite growth and development. Here, we show that an orally bioavailable aminopeptidase inhibitor, CHR-2863, is efficacious against murine malaria. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 5% |
Indonesia | 1 | 3% |
Poland | 1 | 3% |
Unknown | 33 | 89% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 9 | 24% |
Student > Ph. D. Student | 7 | 19% |
Student > Master | 6 | 16% |
Other | 4 | 11% |
Student > Bachelor | 4 | 11% |
Other | 6 | 16% |
Unknown | 1 | 3% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 13 | 35% |
Biochemistry, Genetics and Molecular Biology | 7 | 19% |
Chemistry | 4 | 11% |
Medicine and Dentistry | 4 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 8% |
Other | 3 | 8% |
Unknown | 3 | 8% |